Treatment of candida vaginitis

Phase 1

Recruiting

• Conditions: candida vaginitis.

• Registration Number: IRCT20150624022896N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Women of childbearing age 15-49 years
Married women
Consent to participate in the study
Be literrat
No pregnancy
No breast feeding and menopause
Having 2 symptoms of candida vaginitis (vaginal discharge, itching)
Healthy women (without known immunosuppressive disease, hypertension, diabetes mellitus)
Don’t use of herbal and chemical drugs for vaginitis during recent 2 weeks
No other vaginal infections such as trichomoniasis
Don’t use of any vaginal cream 48 hours before onset of study
No participation in another study at the same time as the present study
Do not use antibiotics and corticosteroids for the past two weeks
No report of allergy to Nivasha spray (containing silver) (if used previously) and clotrimazole (if used previously)
Getting Candida Vaginitis for the First Time

Exclusion Criteria

Mensturation at onset of study
AUB
Antibiotice use for systemic infections during study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vulvar itching. Timepoint: Every day for 10 days. Method of measurement: Vaginal exam - Self report.;Vulvar redness. Timepoint: Every day for 10 days. Method of measurement: Vaginal exam - Self report.;White cheese discharge. Timepoint: Every day for 10 days. Method of measurement: Vaginal exam - Self report.

Secondary Outcome Measures

Name	Time	Method
Vulvar edema. Timepoint: Every day for 10 days. Method of measurement: Vaginal exam - self report.